Unravelling mechanisms for cardiovascular therapeutics
RI-MUHC researchers co-lead a team that combines novel pharmacology with structural biology and computational modelling to discover new domains...
Collaborating with industry to develop lipid nanoparticles
RI-MUHC researcher Julia Burnier heads one of two projects selected for funding by Moderna
Clinical research thrives in Montreal’s West Island
The MUHC Vaccine Study Centre has been conducting top quality vaccine and epidemiological research studies for more than 30 years
New research aims to make prostate cancer prognostics more precise
A team of RI-MUHC researchers is developing DNA biomarkers to better pinpoint treatment options for patients with prostate cancer
New advances in lung cancer treatment
Results of an international clinical trial confirm the efficiency of an immunotherapy treatment for early stage non-small cell lung cancer
Exosomes, vesicles and particles are no longer obscure
The launch of the Centre for Applied Nanomedicine at the RI-MUHC opens an ecosystem of possibilities to the research community
RI-MUHC technology platforms form new partnerships to accelerate research and drug discovery
Partnerships between NMX Research and Solutions, the RI-MUHC...
IDIGH Program gathers at the Glen site for seventh annual research day
Researchers and trainees from the Infectious Diseases and Immunity in Global Health Program at the RI-MUHC enjoyed a stimulating day...
RI-MUHC researchers identify new autophagy-regulating gene
Researchers report how they were able to identify a previously unknown gene involved in regulating autophagy and skeletal muscle integrity
RI-MUHC researchers contribute to two seminal studies of lung and brain cancer
These studies published in Nature demonstrate how big data and artificial intelligence are the future of cancer...